Why the study?
Hypertrophic cardiomyopathy is a common inherited heart disease typically caused by mutations in sarcomere or sarcomere-associated proteins, warranting disease modeling tools.
The successful generation of iPSC lines from HCM patients with TNNI3 mutations provides a validated in vitro model for studying hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
iPSC lines from TNNI3-mutant HCM patients enable in vitro modeling; leaves open mechanistic or therapeutic advances pending further validation.
Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with a prevalence of about 0.2%. HCM is typically caused by mutations in genes encoding sarcomere or sarcomere-associated proteins. Here, we characterized induced pluripotent stem cell (iPSC) lines generated from the peripheral blood mononuclear cells of three HCM patients each carrying c.433C > T, c.610C > T, or c.235C > T mutation in the TNNI3 gene by non-integrated Sendai virus. All of the three lines exhibited normal morphology, expression of pluripotent markers, stable karyotype, and the potential of trilineage differentiation. The cardiomyocytes differentiated from these iPSC lines can serve as useful tools to model HCM in vitro.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: